首页> 美国卫生研究院文献>Protein Science : A Publication of the Protein Society >Presence versus absence of hydrogen bond donor Tyr-39 influences interactions of cationic trypsin and mesotrypsin with protein protease inhibitors
【2h】

Presence versus absence of hydrogen bond donor Tyr-39 influences interactions of cationic trypsin and mesotrypsin with protein protease inhibitors

机译:氢键供体Tyr-39的存在与否会影响阳离子胰蛋白酶和中胰蛋白酶与蛋白蛋白酶抑制剂的相互作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Mesotrypsin displays unusual resistance to inhibition by polypeptide trypsin inhibitors and cleaves some such inhibitors as substrates, despite a high degree of conservation with other mammalian trypsins. Substitution of Arg for the generally conserved Gly-193 has been implicated as a critical determinant of the unusual behavior of mesotrypsin toward protein protease inhibitors. Another relatively conserved residue near the trypsin active site, Tyr-39, is substituted by Ser-39 in mesotrypsin. Tyr-39, but not Ser-39, forms a hydrogen bond with the main chain amide nitrogen of the P4′ residue of a bound protease inhibitor. To investigate the role of the Tyr-39 H-bond in trypsin-inhibitor interactions, we reciprocally mutated position 39 in mesotrypsin and human cationic trypsin to Tyr-39 and Ser-39, respectively. We assessed inhibition constants and cleavage rates of canonical protease inhibitors bovine pancreatic trypsin inhibitor (BPTI) and the amyloid precursor protein Kunitz protease inhibitor domain by mesotrypsin and cationic trypsin variants, finding that the presence of Ser-39 relative to Tyr-39 results in a 4- to 13-fold poorer binding affinity and a 2- to 18-fold increase in cleavage rate. We also report the crystal structure of the mesotrypsin-S39Y•BPTI complex, in which we observe an H-bond between Tyr-39 OH and BPTI Ile-19 N. Our results indicate that the presence of Ser-39 in mesotrypsin, and corresponding absence of a single H-bond to the inhibitor backbone, makes a small but significant functional contribution to the resistance of mesotrypsin to inhibition and the ability of mesotrypsin to proteolyze inhibitors.
机译:尽管与其他哺乳动物胰蛋白酶高度保守,但中胰蛋白酶对多肽胰蛋白酶抑制剂的抑制作用表现出不同寻常的抗性,并切割某些抑制剂作为底物。 Arg替代了通常保守的Gly-193已被认为是中胰蛋白酶对蛋白质蛋白酶抑制剂异常行为的关键决定因素。胰蛋白酶活性部位附近的另一个相对保守的残基Tyr-39被中胰蛋白酶中的Ser-39取代。 Tyr-39(而非Ser-39)与结合的蛋白酶抑制剂的P4'残基的主链酰胺氮形成氢键。为了研究Tyr-39 H键在胰蛋白酶-抑制剂相互作用中的作用,我们分别将中胰蛋白酶和人阳离子胰蛋白酶中的位置39突变为Tyr-39和Ser-39。我们通过中胰蛋白酶和阳离子胰蛋白酶变体评估了规范性蛋白酶抑制剂牛胰胰蛋白酶抑制剂(BPTI)和淀粉样前体蛋白Kunitz蛋白酶抑制剂域的抑制常数和切割速率,发现Ser-39相对于Tyr-39的存在导致了结合亲和力降低4至13倍,切割速率提高2至18倍。我们还报告了中胰蛋白酶-S39Y•BPTI复合物的晶体结构,其中我们观察到了Tyr-39 OH和BPTI Ile-19 N之间的氢键。我们的结果表明,中胰蛋白酶存在Ser-39,并且相应地抑制剂骨架上没有单个H键的存在,对中胰蛋白酶对抑制的抵抗力和中胰蛋白酶对蛋白酶的抑制剂的功能做出了小而重要的功能性贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号